anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

164,041-164,100 of 319,975

filter-aware
04
The slide is divided into two sections: a 2x2 grid for executive bios and a logo grid for investors.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank 1 hit
05
Caribou Biosciences | IPO Presentation Deck | 44 slidesCaribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank 1 hit
06
The slide uses a structured list format to highlight four key pillars of the company's value proposition.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank 1 hit
07
The slide uses a structured grid layout to categorize the company's technology platform and pipeline.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
08
The slide uses a visual comparison framework to contrast traditional autologous therapy with the company's allogeneic focus.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
09
Uses a before-after-bridge style logic to frame the problem (efficacy challenge) and the company's solution (persistence).Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · ProblemLoop · Golden Circle1 hit
10
The chart uses a conceptual line graph to show the impact of two specific genetic modifications on the duration of CAR-T cell activity.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
11
The slide uses a standard pharmaceutical pipeline visualization format.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
12
The slide serves as a section divider or introduction to the technology stack.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
13
Caribou Biosciences | IPO Presentation Deck | 44 slidesCaribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
14
The slide uses a process flow diagram to show the transition from raw materials to patient treatment.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
15
The charts show that chRDNA guides maintain high on-target editing while significantly reducing off-target editing compared to all-RNA guides.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · TractionLoop · Zoom In1 hit
16
Caribou Biosciences | IPO Presentation Deck | 44 slidesCaribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · TractionLoop · Zoom In1 hit
17
The chart is a flow cytometry plot showing insertion efficiency across two inserts.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · TractionLoop · Zoom In1 hit
18
The slide uses a before/after diagram to explain the biological problem of translocation and a comparative box to show the performance improvement.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · TractionLoop · Zoom In1 hit
19
Caribou Biosciences | IPO Presentation Deck | 44 slidesCaribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
20
The slide uses a comparison table to demonstrate the competitive advantages of CB-010's specific gene-editing features.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
21
Uses a before-after comparison framework to explain the mechanism of action.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
22
Includes bioluminescence imaging time-series and Kaplan-Meier survival curve.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
23
Kaplan-Meier survival plots are standard for preclinical efficacy demonstration.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
24
The slide outlines a standard 3+3 dose escalation clinical trial design.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
25
The slide details the transition from healthy donor leukapheresis through genetic modification (using AAV, Cas9, and chRDNA) to final cryopreservation and treatment.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
26
Caribou Biosciences | IPO Presentation Deck | 44 slidesCaribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
27
The slide features a stylized microscopic image of cells, likely T-cells, as a background.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
28
The slide uses a checkmark/cross comparison table to demonstrate competitive advantage.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
29
The slide uses a biological process diagram to illustrate the 'cloaking' mechanism.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
30
The chart shows in vitro cytotoxicity measured 24 hours after co-incubation at various effector-to-target ratios.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
31
Kaplan-Meier survival curves showing superior efficacy of CB-011.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
32
Caribou Biosciences | IPO Presentation Deck | 44 slidesCaribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
33
Caribou Biosciences | IPO Presentation Deck | 44 slidesCaribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
34
The slide uses a checkmark vs X comparison table to establish competitive advantage.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
35
The chart is a Kaplan-Meier survival plot. The p-value < 0.0001 indicates statistical significance.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
36
Caribou Biosciences | IPO Presentation Deck | 44 slidesCaribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · Traction1 hit
37
The slide features a stylized illustration of a cell, likely an NK cell, interacting with other cells.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank 1 hit
38
The diagram shows a multi-step biological process: Gene editing, two stages of differentiation, and expansion.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank 1 hit
39
The slide presents four distinct assays validating the functional equivalence of iNK cells to primary NK cells.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank 1 hit
40
Caribou Biosciences | IPO Presentation Deck | 44 slidesCaribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank 1 hit
41
Caribou Biosciences | IPO Presentation Deck | 44 slidesCaribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank 1 hit
42
The slide uses a split-column layout to contrast past performance with future roadmap items.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank 1 hit
43
The slide uses a structured list format to highlight four key pillars of the company's value proposition.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank 1 hit
44
Caribou Biosciences | IPO Presentation Deck | 44 slidesCaribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank 1 hit
01
Slide 1
Central Pacific Financial | Results Presentation Deck | 13 slidesCentral Pacific Financial | Results Presentation Deck | 13 slides · Central Pacific Financial
Conference presentation Investor relations 1 hit
02
Central Pacific Financial | Results Presentation Deck | 13 slidesCentral Pacific Financial | Results Presentation Deck | 13 slides · Central Pacific Financial
Conference presentation Investor relations 1 hit
03
Includes a footnote regarding PPP normalization.Central Pacific Financial | Results Presentation Deck | 13 slides · Central Pacific Financial
Conference presentation Investor relations Beat · Attention1 hit
04
Data as of 6/30/21; values in $ millions.Central Pacific Financial | Results Presentation Deck | 13 slides · Central Pacific Financial
Conference presentation Investor relations Beat · Interest1 hit
05
Includes dual-axis charts combining bar and line elements to show absolute values and ratios.Central Pacific Financial | Results Presentation Deck | 13 slides · Central Pacific Financial
Conference presentation Investor relations Beat · Interest1 hit
06
The slide uses a multi-colored line chart to represent a timeline of events.Central Pacific Financial | Results Presentation Deck | 13 slides · Central Pacific Financial
Conference presentation Investor relations Loop · Aha Moment1 hit
07
Central Pacific Financial | Results Presentation Deck | 13 slidesCentral Pacific Financial | Results Presentation Deck | 13 slides · Central Pacific Financial
Conference presentation Investor relations Beat · Desire1 hit
08
Central Pacific Financial | Results Presentation Deck | 13 slidesCentral Pacific Financial | Results Presentation Deck | 13 slides · Central Pacific Financial
Conference presentation Investor relations Beat · Desire1 hit
09
The pie chart visualizes the breakdown of the $5,077MM total loan portfolio.Central Pacific Financial | Results Presentation Deck | 13 slides · Central Pacific Financial
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
10
Central Pacific Financial | Results Presentation Deck | 13 slidesCentral Pacific Financial | Results Presentation Deck | 13 slides · Central Pacific Financial
Conference presentation Investor relations Beat · Action1 hit
11
Central Pacific Financial | Results Presentation Deck | 13 slidesCentral Pacific Financial | Results Presentation Deck | 13 slides · Central Pacific Financial
Conference presentation Investor relations 1 hit
12
Includes a link to the full report and a visual representation of the report cover.Central Pacific Financial | Results Presentation Deck | 13 slides · Central Pacific Financial
Conference presentation Investor relations 1 hit
13
The table provides a bridge between GAAP reported figures and adjusted figures by removing PPP-related impacts.Central Pacific Financial | Results Presentation Deck | 13 slides · Central Pacific Financial
Conference presentation Investor relations 1 hit
01
Slide 1
Crocs | Investor Presentation Deck | 30 slidesCrocs | Investor Presentation Deck | 30 slides · Crocs
Conference presentation Investor relations 1 hit
02
Crocs | Investor Presentation Deck | 30 slidesCrocs | Investor Presentation Deck | 30 slides · Crocs
Conference presentation Investor relations 1 hit
03
Crocs | Investor Presentation Deck | 30 slidesCrocs | Investor Presentation Deck | 30 slides · Crocs
Conference presentation Investor relations 1 hit
04
Crocs | Investor Presentation Deck | 30 slidesCrocs | Investor Presentation Deck | 30 slides · Crocs
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
05
Crocs | Investor Presentation Deck | 30 slidesCrocs | Investor Presentation Deck | 30 slides · Crocs
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
06
Crocs | Investor Presentation Deck | 30 slidesCrocs | Investor Presentation Deck | 30 slides · Crocs
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit